The Food and Drug Administration gave the status — which is designed to speed a drug through the approval process if it addresses a significant unmet medical need — for use of Nuvelo’s drug known as rNAPc2 as both a first-line treatment and second-line treatment, both in combination with chemotherapy, against metastatic colorectal cancer.
The […]
-
Tags
- Cancer News
- Cancer Story
- breast-cancer
- breast_cancer
- american_cancer_society
- cervical_cancer
- cancer_patients
- journal_cancer
- prostate_cancer
- metastatic_breast_cancer
- cancer_treatment
- colorectal_cancer
- john_edwards
- cervical_cancer_vaccine
- cancer_drugs
- breast_cancer_patients
- colon_cancer
- cancer_vaccine
- word_cancer
- cancer_vaccines
- cancer_therapies
- cancer_researchers
- cancer_deaths
- elizabeth_edwards
- cancer
- breast_cancer_cases
- cancer-drug
- breast_cancer_research
- BREAST-CANCER-RISK
- cancer_center
-
Archives
